NOVEL CELLULAR & GENETIC ANALYSES USING A NEW CHLAMYDIA PENETRANT PEPTIDE
新颖的蜂窝
基本信息
- 批准号:8281426
- 负责人:
- 金额:$ 17.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-06-15 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsAnimalsAntisense OligonucleotidesAttenuatedBacterial GenesBiologyCase StudyCellsChlamydiaChlamydia trachomatisChronicChronic DiseaseClinical DataColumnar EpitheliumCytokine Inducible SH2-Containing ProteinDataDevelopmentDioxygenasesDiseaseEducationEndocervixEpithelial CellsFemaleFertilityGenesGeneticGenetic TechniquesGenital systemGenitourinary systemGoalsHabitatsHealthHealth Care CostsHourHumanImmuneImmune TargetingImmune responseImmunologyIn VitroInfectionInterferon Type IIInterferonsInterventionInvadedLabelLifeMediatingMediator of activation proteinMethodsMolecularMolecular BiologyNeonatalNucleic AcidsOrganismPathogenesisPathway interactionsPeptide Nucleic AcidsPeptidesPhysiologicalPopulationProtein BiosynthesisProteinsPublic HealthRegulationResearchRoleScreening procedureSignal TransductionSorting - Cell MovementTechnologyTestingTimeTryptophanUnited States National Institutes of HealthVirulenceWomanattenuationgenetic analysishuman femalein vivoindoleamineinnovationmenneonatenovelpathogenpositional cloningreproductiveresearch studyresponseskillstooltransmission process
项目摘要
DESCRIPTION (provided by applicant): The objectives of this proposal are to elucidate the mechanism by which Chlamydia trachomatis evades the immune response by attenuating IFN?-dependent signaling in infected host cells, and to develop a new reverse genetic strategy to study C. trachomatis pathogenesis and biology.
Sexually transmitted C. trachomatis infections, primarily caused by serovars D-F, are a major public health concern with adverse effects on female fertility and neonatal health. Despite significant public health interventions including education, screening and treatment, reported cases n the US reached 1 million in 2006 and continue to rise, resulting in annual health care costs >$2.4 billion. Asymptomatic infections in >70% of women and >30% of men, can take months to years to resolve, and thereby compounding transmission of C. trachomatis. Transmission is exacerbated by short-lived protection to re-infection. In vitro studies in human epithelial cells, and animal studies using C. muridarum, have demarcated IFN? as a major anti-chlamydial mediator. In vivo, although elevated IFN??is found in the infected human endocervix, clinical data indicate that C. trachomatis can evade immune responses.
We have developed an innovative approach using a novel penetrant peptide (CPP) to label C. trachomatis Elementary Bodies (EB). Our approach has permitted the isolation of pure populations of infected endocervical epithelial cells, from mixed pools of cells exposed to C. trachomatis. Analyses of pure populations has revealed that C. trachomatis attenuates IFN?-dependent expression of indoleamine-2,3-dioxygenase (IDO1). Attenuation permits C. trachomatis, a tryptophan auxotroph, to ameliorate the effect of intracellular tryptophan depletion by IDO1. The first goal of this application is to understand how Chlamydia blocks host-cell IFN?-dependent signaling. Understanding this mechanism will permit development of new strategies that target immune evasion by C. trachomatis.
The paucity of easily applicable genetic tools to manipulate C. trachomatis has limited the capacity to investigate mechanisms employed by C. trachomatis that drive immune evasion and pathogenesis. This application addresses this significant deficiency by proposing an innovative approach using the same CPP to carry cargoes that repress expression of specific C. trachomatis genes. When developed and validated, our strategy will permit robust reverse genetic approaches to molecularly dissect virulence determinants of C. trachomatis.
These studies with our novel CPP will significantly shift current paradigms and revolutionize approaches in Chlamydia research by: 1) Establishing a robust method to elucidate previously unidentified immune evasion strategies used by C. trachomatis; and 2) Providing, for the first time, a robust reverse genetic technique to dissect the role of specific bacterial genes in the developmental cycle and pathogenesis.
描述(由申请方提供):本提案的目的是阐明沙眼衣原体通过减弱IFN?-γ逃避免疫应答的机制。依赖的信号转导,并开发一种新的反向遗传策略来研究C.沙眼的发病机制和生物学。
性传播C。主要由血清型D-F引起的沙眼感染是一个主要的公共卫生问题,对女性生育力和新生儿健康有不利影响。尽管采取了包括教育、筛查和治疗在内的重大公共卫生干预措施,但美国报告的病例在2006年达到100万,并继续上升,导致每年的医疗保健费用> 24亿美元。在>70%的女性和>30%的男性中,无症状感染可能需要数月至数年才能解决,从而加剧了C。 沙眼对再次感染的保护期短,会加剧传播。在人类上皮细胞中的体外研究和使用C. muridarum,已划定干扰素?作为主要的抗衣原体介质。在体内,虽然IFN?临床资料表明,C.沙眼可以逃避免疫反应。
我们已经开发了一种创新的方法,使用一种新的渗透肽(CPP)标记C。 沙眼原体(EB)。我们的方法可以从暴露于C.沙眼纯种群分析表明,C.沙眼使IFN?减弱吲哚胺-2,3-双加氧酶(IDO 1)的依赖性表达。衰减允许C。沙眼衣原体,色氨酸营养缺陷型,以改善IDO 1对细胞内色氨酸消耗的影响。本申请的第一个目标是了解衣原体如何阻断宿主细胞IFN?-依赖信号了解这一机制将有助于开发针对C.沙眼
缺乏易于应用的遗传工具来操纵C。沙眼衣原体的研究限制了研究沙眼衣原体机制的能力。导致免疫逃避和发病的沙眼。本申请通过提出一种创新的方法来解决这一重大缺陷,该方法使用相同的CPP来运载抑制特定C的表达的货物。沙眼相关基因当开发和验证,我们的策略将允许强大的反向遗传方法,从分子上剖析C。 沙眼
这些研究与我们的新的CPP将显着改变当前的范式和革命性的方法在衣原体研究:1)建立一个强大的方法来阐明以前未确定的免疫逃避策略使用的衣原体。沙眼;和2)首次提供了一种强大的反向遗传技术来剖析特定细菌基因在发育周期和发病机制中的作用。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The High-Risk Human Papillomavirus E6 Oncogene Exacerbates the Negative Effect of Tryptophan Starvation on the Development of Chlamydia trachomatis.
高风险人乳头瘤病毒 E6 癌基因加剧了色氨酸饥饿对沙眼衣原体发育的负面影响。
- DOI:10.1371/journal.pone.0163174
- 发表时间:2016
- 期刊:
- 影响因子:3.7
- 作者:Sherchand,ShardulendraP;Ibana,JoyceA;Zea,ArnoldH;Quayle,AlisonJ;Aiyar,Ashok
- 通讯作者:Aiyar,Ashok
Chlamydia trachomatis-infected cells and uninfected-bystander cells exhibit diametrically opposed responses to interferon gamma.
- DOI:10.1038/s41598-018-26765-y
- 发表时间:2018-05-31
- 期刊:
- 影响因子:4.6
- 作者:Ibana JA;Sherchand SP;Fontanilla FL;Nagamatsu T;Schust DJ;Quayle AJ;Aiyar A
- 通讯作者:Aiyar A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ashok A Aiyar其他文献
Ashok A Aiyar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ashok A Aiyar', 18)}}的其他基金
Factors that modulate the deleterious effect of ammonia generation by chlamydial tryptophan synthase
调节衣原体色氨酸合酶产生氨有害作用的因素
- 批准号:
10040215 - 财政年份:2020
- 资助金额:
$ 17.75万 - 项目类别:
Factors that modulate the deleterious effect of ammonia generation by chlamydial tryptophan synthase
调节衣原体色氨酸合酶产生氨有害作用的因素
- 批准号:
10198719 - 财政年份:2020
- 资助金额:
$ 17.75万 - 项目类别:
Consequences of vaginal microbiota on IFNγ-mediated clearance of Chlamydia trachomatis
阴道微生物群对 IFNγ 介导的沙眼衣原体清除的影响
- 批准号:
9240286 - 财政年份:2017
- 资助金额:
$ 17.75万 - 项目类别:
Consequences of vaginal microbiota on IFNγ-mediated clearance of Chlamydia trachomatis
阴道微生物群对 IFNγ 介导的沙眼衣原体清除的影响
- 批准号:
9540785 - 财政年份:2017
- 资助金额:
$ 17.75万 - 项目类别:
NOVEL CELLULAR & GENETIC ANALYSES USING A NEW CHLAMYDIA PENETRANT PEPTIDE
新颖的蜂窝
- 批准号:
8166018 - 财政年份:2011
- 资助金额:
$ 17.75万 - 项目类别:
Characterization and use of a novel AT-hook protein in Leishmania
利什曼原虫新型 AT-hook 蛋白的表征和应用
- 批准号:
8071117 - 财政年份:2010
- 资助金额:
$ 17.75万 - 项目类别:
Characterization and use of a novel AT-hook protein in Leishmania
利什曼原虫新型 AT-hook 蛋白的表征和应用
- 批准号:
7896108 - 财政年份:2010
- 资助金额:
$ 17.75万 - 项目类别:
Functions of EBNA1 in replication & partitioning of EBV
EBNA1 在复制中的功能
- 批准号:
7116680 - 财政年份:2005
- 资助金额:
$ 17.75万 - 项目类别:
Functions of EBNA1 in replication & partitioning of EBV
EBNA1 在复制中的功能
- 批准号:
6937180 - 财政年份:2005
- 资助金额:
$ 17.75万 - 项目类别:
Functions of EBNA1 in replication & partitioning of EBV
EBNA1 在复制中的功能
- 批准号:
7287380 - 财政年份:2005
- 资助金额:
$ 17.75万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 17.75万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 17.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 17.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 17.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 17.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 17.75万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 17.75万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 17.75万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 17.75万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 17.75万 - 项目类别:
Discovery Grants Program - Individual